Advani, Pooja P <br/><br/>
Pharmacokinetic evaluation of oblimersen sodium for the treatment of chronic lymphocytic leukemia.  [electronic resource] 

 -  Expert opinion on drug metabolism & toxicology  Jun 2011 
 - 765-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7607 
<br/><br/><label>Standard No.: </label>10.1517/17425255.2011.579105  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--pharmacokinetics<br/>B-Lymphocytes--metabolism<br/>Clinical Trials as Topic<br/>Dose-Response Relationship, Drug<br/>Down-Regulation<br/>Drug Evaluation<br/>Drug Evaluation, Preclinical<br/>Drug and Narcotic Control--legislation & jurisprudence<br/>Gene Expression Regulation, Neoplastic<br/>Genes, bcl-2<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Proto-Oncogene Proteins c-bcl-2--genetics<br/>RNA, Messenger--genetics<br/>Thionucleotides--pharmacokinetics